What is Eli Lilly xStock (LLYX)?
Quick Facts
- Issuer: Backed Finance AG, a Swiss-based fintech founded in 2021
- Underlying asset: Eli Lilly and Company (NYSE: LLY) shares
- Collateral model: 1:1 backing by real shares in regulated custody
- Token structure: Bearer debt instrument (tracker certificate)
- Regulatory approval: Liechtenstein FMA under EU Prospectus Regulation
- Availability: Non-US users only
- Networks: Solana, Arbitrum, and other EVM-compatible chains
- Trading: 24/7 on-chain settlement
Introduction
Eli Lilly xStock (LLYX) is a tokenized representation of Eli Lilly and Company shares, issued by Backed Finance as part of the xStocks product line. It gives eligible crypto-native investors price exposure to one of the world's leading pharmaceutical companies — entirely on-chain, without requiring a traditional brokerage account.
Eli Lilly is a global pharmaceutical firm known for its innovations in areas such as cardiometabolic health, oncology, and neuroscience. LLYX mirrors the performance of LLY stock while living natively on public blockchains.
History & Background
Backed Finance was founded in 2021 by three former DAOstack team members who were inspired by the growing adoption of stablecoins. Their goal was to bring traditional financial instruments — equities, ETFs, and bonds — onto blockchain infrastructure in a fully compliant manner.
Between 2021 and 2022, Backed completed seed funding, established partnerships with custodian banks, and secured EU regulatory approval for its product prospectuses. The xStocks platform launched in June 2025, and LLYX was among its early tokenized equity offerings.
How Eli Lilly xStock Works
Every LLYX token is backed 1:1 by a real Eli Lilly share, purchased by Backed Finance and held by a licensed third-party custodian — such as Swiss banks InCore Bank or Maerki Baumann.
Legally, LLYX is structured as a tracker certificate — a bearer debt instrument that reflects the performance of the underlying equity without conferring direct share ownership. The issuing entity is Backed Assets (JE) Limited, a private company domiciled in Jersey.
Chainlink Proof of Reserve enables on-chain, continuous verification that the number of real shares in custody always matches the number of tokens in circulation.
Tokenomics
LLYX tokens are minted when qualified investors purchase them through Backed's platform or approved exchange partners, and are burned upon redemption. This demand-driven model means the token supply expands and contracts with user activity, always remaining fully collateralized.
The token has no inflationary issuance, staking rewards, or governance allocations. Its economic design is straightforward: each token represents a unit of economic exposure to LLY stock, priced accordingly at all times.
|
Circulating Supply
| 866 LLYX |
|---|---|
|
Total supply
| 113,600 LLYX |
|
Max supply
| -- LLYX |
Ecosystem & Use Cases
Because xStocks are permissionless post-issuance, LLYX can be freely transferred and used within DeFi protocols — for example, as collateral in lending platforms or traded on decentralized exchanges.
Trading is available around the clock on both centralized platforms (such as Kraken and Gate.io) and decentralized venues, enabling settlement at any hour — unlike traditional stock markets with fixed trading windows.
Team, Governance & Community
Backed Finance AG operates from Switzerland and issues tokens via its Jersey-based subsidiary, Backed Assets (JE) Limited. The project follows a centralized governance model typical of regulated financial products — token holders do not vote on protocol changes.
The xStocks social community is active on X (Twitter) and Telegram under the handle @xStocksFi.
Advantages
- Regulated structure: EU Prospectus Regulation approval via the Liechtenstein FMA provides a recognized compliance framework.
- 1:1 real-share backing: Every token is fully collateralized by actual LLY shares in licensed custody.
- 24/7 access: On-chain settlement removes traditional market-hours restrictions.
- DeFi composability: LLYX can be used across decentralized protocols without additional wrapping.
- No brokerage required: Non-US crypto users gain equity exposure without a US brokerage account.
Risks & Challenges
- US investors excluded: SEC restrictions mean LLYX is not available to US-domiciled users.
- No smart contract audits: No major auditing firm has published a public audit of Backed Finance's token contracts.
- Custodian dependency: The 1:1 backing relies on off-chain custodians, introducing centralized trust assumptions.
- Limited shareholder rights: Token holders do not automatically receive voting rights or dividends.
- After-hours price drift: Since crypto markets run 24/7, prices may diverge from the underlying stock when traditional markets are closed.
Long-Term Vision
LLYX sits at the intersection of real-world asset (RWA) tokenization and decentralized finance. Backed Finance's broader ambition is to make global blue-chip equities, ETFs, and bonds accessible on-chain to any eligible investor worldwide.
As regulatory clarity around tokenized securities continues to develop across jurisdictions, products like LLYX are positioned as early infrastructure for the on-chain capital markets of the future — bridging traditional finance and the open, permissionless blockchain ecosystem.
Frequently Asked Questions
- What is LLYX?
LLYX is a tokenized version of Eli Lilly and Company (LLY) stock, issued by Backed Finance as part of the xStocks ecosystem. Each token tracks the price of LLY and is backed 1:1 by a real share held in regulated custody.
- Who issues LLYX?
LLYX is issued by Backed Assets (JE) Limited, the Jersey-based issuing subsidiary of Backed Finance AG, a Swiss fintech founded in 2021. The product operates under regulatory approval from the Liechtenstein Financial Market Authority under the EU Prospectus Regulation.
- Is LLYX actually backed by real Eli Lilly shares?
Yes. Every LLYX token is collateralized 1:1 by a real LLY share purchased by Backed Finance and held by licensed custodian banks in Switzerland. Chainlink Proof of Reserve enables continuous on-chain verification of this backing.
- What type of financial instrument is LLYX legally?
LLYX is structured as a tracker certificate — a bearer debt instrument that mirrors the performance of Eli Lilly stock without granting direct equity ownership. This means holders do not automatically receive voting rights or dividend payments.
- Can US investors buy LLYX?
No. Due to SEC regulatory restrictions, LLYX and all other xStocks products are only available to non-US users. US-domiciled investors are prohibited from purchasing or holding these tokens.
- On which blockchains is LLYX available?
LLYX is available natively on Solana (as an SPL token) and on Arbitrum (as an ERC-20 token), among other EVM-compatible networks. This multi-chain deployment supports broad DeFi composability and trading access.
- Can LLYX be used in DeFi protocols?
Yes. Because xStocks are permissionless after issuance, LLYX can be freely transferred and used within decentralized finance applications such as lending platforms and decentralized exchanges — for example, as collateral.
- What are the main risks of holding LLYX?
Key risks include custodian counterparty dependency, absence of published smart contract audits from major auditing firms, exclusion of US investors, potential price divergence from the underlying stock during off-market hours, and limited shareholder rights for token holders.